Disintegration Test Performance

Disintegration test performance measures tablet and capsule breakup into fine particles within specified timeframes. USP apparatus employing oscillating baskets in aqueous medium simulate gastrointestinal conditions. Pass/fail criteria establish maximum disintegration time. Modified-release formulations exhibit extended disintegration. Enteric-coated products resist stomach pH preventing premature dissolution.

Specification compliance ensures consistent drug release. Formulation variations affecting disintegrant efficacy require investigation. Regulatory inspections verify test methodology compliance. Post-approval monitoring confirms continued disintegration performance. Emerging modified apparatus better simulate physiological conditions.